Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 15, 2018
Oncobiologics Reports Second Quarter Financial Results for Fiscal 2018
CRANBURY, N.J., May 15, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (ONS) today reported financial results and business highlights for its three and six months ended ...
May 15, 2018
Molecular Templates to Present at the UBS Global Healthcare Conference
AUSTIN, Texas, May 15, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (MTEM) (“Molecular”), a clinical-stage oncology company focused on the discovery and development of the ...
May 15, 2018
AIT Therapeutics to Present Data from Its Inhaled Nitric Oxide Study in Patients Infected with Mycobacterium Abscessus Complex at the 2018 American Thoracic Society Conference
NEW YORK, May 15, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ...
May 15, 2018
Celyad announces launch of proposed global offering
MONT-SAINT-GUIBERT, Belgium, May 15, 2018 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (CYAD) (CYAD), a clinical-stage biopharmaceutical company focused on the development of specialized CAR-T cell ...
May 15, 2018
Celyad Announces First Quarter 2018 Business Update
MONT-SAINT-GUIBERT, Belgium, May 15, 2018 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (Euronext Paris:CYAD) (CYAD), a clinical-stage biopharmaceutical company focused on the development of specialized CAR-T cell ...
May 14, 2018
ADMA Biologics Retires Approximately 8.6 Million Shares Previously Issued to Biotest
RAMSEY, N.J. and BOCA RATON, Fla., May 14, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”) announced today that it has ...
May 14, 2018
iCAD Reports First Quarter 2018 Financial Results
NASHUA, N.H., May 14, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today reported ...
May 14, 2018
Vermillion Reports First Quarter 2017 Financial Results
AUSTIN, Texas, May 14, 2018 (GLOBE NEWSWIRE) -- Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, reported on its financial results for ...
May 14, 2018
Acer Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
NEWTON, Mass., May 14, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for ...
May 14, 2018
Pfenex Announces Positive Top-Line PF708 Study Results in Osteoporosis Patients, On-Track for Submission of New Drug Application in Third Quarter 2018
SAN DIEGO, May 14, 2018 /PRNewswire/ -- Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression Technology® ...
May 14, 2018
Zealand hosts conference call on May 16 at 4 pm CET/10 am EDT to present first quarter results 2018
Copenhagen, May 14, 2017 - Zealand Pharma A/S ("Zealand") (CVR no. 20 04 50 78) announces that it will be hosting a conference call on ...
May 14, 2018
CytoSorb® Adds Bilirubin and Myoglobin Reduction to European Union Approved Indications for Use
MONMOUTH JUNCTION, N.J., May 14, 2018 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly ...
May 14, 2018
Arrowhead Doses First Hepatitis B Patients in Multiple Dose Portion of Phase 1/2 Study of ARO-HBV
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that it has dosed the first 3 hepatitis B virus (HBV) patients in the multiple-ascending dose portion ...
May 14, 2018
Auris Medical to Report First Quarter 2018 Financial Results and Provide Business and Strategy Update on Tuesday, May 15, 2018
Zug, Switzerland, May 14, 2018 - Auris Medical Holding AG (EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in ...
May 14, 2018
Zogenix to Participate in the Bank of America Merrill Lynch 2018 Healthcare Conference
EMERYVILLE, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
May 14, 2018
Soleno Therapeutics Announces Initiation of Phase III Clinical Trial of DCCR in Prader-Willi Syndrome
REDWOOD CITY, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of ...
May 14, 2018
RedHill Biopharma to Host Investor Webcast on RHB-104 for Crohn’s Disease on May 15
TEL-AVIV, Israel and RALEIGH, N.C., May 14, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical ...
May 14, 2018
BrainStorm Announces First Quarter 2018 Financial Results and Provides Corporate and Clinical Highlights
NEW YORK, N.Y. and PETACH TIKVAH, Israel, May 14, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies ...
May 14, 2018
PolarityTE Acquires Operating GLP/USDA Preclinical Biomedical Research Facility and Announces Caroline Garrett DVM from Johns Hopkins as Chief Veterinary Officer at Polarity
SALT LAKE CITY, May 14, 2018 (GLOBE NEWSWIRE) -- PolarityTE™, Inc. (COOL) announced the acquisition of a preclinical biomedical research facility in order to accelerate ...
May 14, 2018
Oncobiologics Announces $15 Million Private Placement Offering
CRANBURY, N.J., May 14, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (ONS) (the “Company”) today announced that on May 11, 2018, it entered into a purchase ...
Page 41 of 117